my answer to that question was based on what we know about the...

my answer to that question was based on what we know about the company as of today the 26th Dec 23. By the time we get to 31st Dec '24, and we've got the results of the next 3 Ph II trials of 2591, plus a plan for a Ph III trial, plus more royalty revenue growth of Daybue, plus some indication of trials of Daybue or 2591 by Acadia for Fragile X, our answers could be much higher anyway. I expect NEU will be a much more valuable company by the end of next year, that probably still won't be fully appreciated by the Australian investing community. That's why my guess for the share price for NEU at the end of next year is only $65 but a takeover offer will need to be at least 4 times that to be successful.